Vulvar Lichen Sclerosus
Conditions
Interventions
Women divided into 2 groups: case group (20 patients) and control group (20 patients). Patients in the case group will maintain topical treatment with high-potency corticosteroids and will be held 3 s
Sponsors
Universidade Federal Fluminense
Universidade Federal Fluminense
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Histopathological diagnosis of vulvar lichen sclerosus being treated with corticosteroids.
Exclusion criteria
Exclusion criteria: HIV positive women, malignant neoplasms, pregnant women, use of systemic immunosuppressants, no desire to participate in the research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find clinical improvement in Vulvar Lichen Sclerosus using the fractional microablative radiofrequency method based on the verification of p values ??less than 0.05, which will be considered significant for differences between groups or for association between categorical variables. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to find histopathological improvement in Vulvar Lichen Sclerosus using the fractional microablative radiofrequency method based on the verification of p values ??less than 0.05, which will be considered significant for differences between groups or for association between categorical variables. | — |
Countries
Brazil
Contacts
Public ContactRenata Guimarães
Universidade Federal Fluminense
Outcome results
None listed